ClinicalTrials.Veeva

Menu

Caffeine Versus Placebo for Spinal Headaches

U

United States Naval Medical Center, Portsmouth

Status

Withdrawn

Conditions

Post Dural Puncture Headache

Treatments

Drug: Caffeine
Drug: saline

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT00809627
CIP 2006 0051

Details and patient eligibility

About

Caffeine will be studied against placebo in patients with positional headache after a lumbar puncture (aka "spinal headache").

Full description

Pain will be assessed at set intervals using a Visual Analog Scale. Blood patch therapy will be offered to all those still in pain at the end of one hour after drug administration.

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with post dural puncture headache

Exclusion criteria

  • age < 18
  • pregnant
  • allergic to caffeine
  • cardiac or peripheral vascular disease
  • uncontrolled hypertension

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

0 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
IV caffeine with saline and opiate
Treatment:
Drug: Caffeine
2
Placebo Comparator group
Description:
IV saline with opiate
Treatment:
Drug: saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems